🔗 Share this article

Treasury head Rachel Reeves has stated she is planning "specific steps to address cost of living challenges" in the forthcoming financial statement.

In comments to the BBC, she emphasized that reducing price rises is a shared duty of both the administration and the central bank.

The United Kingdom's inflation rate is forecast to be the highest among the G7 advanced economies this calendar year and the following year.

Possible Energy Cost Interventions

Sources suggest the administration could intervene to lower energy bills, such as by cutting the present 5% rate of VAT charged on energy.

An additional approach is to cut some of the government charges presently included in household expenses.

Budgetary Limitations and Expert Predictions

The government will obtain the latest assessment from the official forecaster, the OBR, on the start of the week, which will reveal how much space there is for these actions.

The consensus from the majority of analysts is that Reeves will have to announce higher taxes or expenditure reductions in order to fulfill her declared fiscal targets.

Previously on Thursday, calculations indicated there was a £22 billion deficit for the chancellor to address, which is at the more modest range of expectations.

"There's a collective responsibility between the Bank of England and the administration to continue tackling some of the sources of price increases," Reeves told reporters in Washington, at the conferences of the IMF and World Bank.

Tax Pledges and International Concerns

While a great deal of the focus has been on likely tax increases, the Treasury chief said the latest information from the fiscal watchdog had not changed her commitment to campaign commitments not to raise rates on earnings tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with rising geopolitical and commercial issues for the Budget tax moves, likely to be targeted on those "wealthiest."

International Trade Disputes

Commenting on concerns about the United Kingdom's commercial links with China she said: "The UK's security interests invariably take priority."

Last week's declaration by Chinese authorities to increase export controls on rare earths and other materials that are crucial for advanced tech manufacturing led American leader Donald Trump to suggest an extra 100% tariff on imports from the Asian country, increasing the possibility of an all-out trade war between the two economic giants.

The American finance chief described China's move "commercial pressure" and "a global supply chain power grab."

Inquired about considering the American proposal to participate in its battle with China, the Chancellor said she was "deeply worried" by Chinese measures and encouraged the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "damaging for the world economy and creates further challenges."

"I believe there are fields where we should confront China, but there are also important prospects to sell into Chinese markets, including financial services and other areas of the economic system. We've got to maintain that equilibrium right."

The Treasury chief also affirmed she was collaborating with international partners "on our own essential resources plan, so that we are more independent."

Health Service Medicine Pricing and Funding

Reeves also recognized that the price the National Health Service pays for pharmaceuticals could rise as a result of current negotiations with the US government and its pharmaceutical firms, in exchange for lower tariffs and funding.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or abandoning operations in the United Kingdom, with several blaming the low prices they are obtaining.

Last month, the Science Minister said the price the health service pays for medicines would need to rise to stop firms and drug research funding leaving the United Kingdom.

Reeves stated to media: "We have seen because of the pricing regime, that drug testing, recent pharmaceuticals have not been available in the UK in the manner that they are in other EU nations."

"We want to make sure that individuals receiving treatment from the National Health Service are can access the top critical medicines in the globe. And so we are reviewing this situation, and... seeking to secure increased capital into Britain."